Login to Your Account



Big Day For Pfizer: Sutent, Exubera Receive Approvals

By Aaron Lorenzo


Monday, January 30, 2006
The much-anticipated arrival of Sutent (sunitinib) in the oncology space occurred last week - and did so with a bang: It received FDA approval for two indications at once, an agency first for a cancer product. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription